1Stanescu D, Sanna A, Venter C,et al.Airways obstruction, chronic ex-pectoration and rapid decline of FEV 1 in smokers are associated with in-creased levels of sputum neutrophils[J].Thorax,1996;51(1):267-71.
2Aaron SD,Angel JB,Lunau M,et al.Granulocyte inflammatory markersand airway infection during acute exacerbation of chronic obstructive pul-monary disease[J].Am J Respir Crit Care Med,2001, 163(7):349-55.
3Keatings VM,Barnes PJ.Granulocyte activation markers in induced sputum:comparison between chronic obstructive pulmonary disease, asthma, and nor-mal subjects[J], Am J Respir Crit Care Med, 1997; 155(1):449-53.
4Gan WQ,Man SF,Senthilselvan A,et al.Association between chronic ob-structive pulmonary disease and systemic inflammation: a systematic re-view and a meta-analysis[ J ].Thorax ,2004,59(1),574-80.
7Yamaryo T, Oishi K, Yoshimine H, et al.Fourteen-member macrolidespromote the phosphatidylserine receptor-dependent phagocytosis of apop-totic neutrophils by alveolar macrophages[J].Antimicrob Agents Che-mother,2003,47(1):48-53.
8He Z,Li B,Yu L,et al.Suppression of oxidant-induced glutathione syn-thesis by erythromycin in human bronchial epithelial cells[J].Respira-tion,2008,75(2):202-9.
9Seemungal TA,Wilkinson TM, Hurst JR, et al.Longterm erythromycintherapy is associated with decreased chronic obstructive pulmonary dis-ease exacerbations[J].Am J Respir Crit Care Med,2008, 178(1):1139-47.
10Suzuki T,Yanai M,Yamaya M,et al.erythromycin and common cold inCOPD[J].Chest,2001,120(4):730-3.
2Marescaux A, Degano B, Soumagne T, et al. Impact of farm moderni-ty on the prevalence of chronic obstructive pulmonary disease in dairy farmers[J]. Occup Environ Med, 2016,73(2) :127-133.
3Yang H, Xiang P, Zhang E, et al. Is hypercapnia associated with poor prognosis in chronic obstructive pulmonary disease? A long-term follow-up cohort study[ J]. BMJ Open ,2015,5 (12) :e008909.
4Sun X J, Li ZH, Zhang Y, et al. Combination of erythromycin and dexamethasone improves corticosteroid sensitivity induced by CSE through inhibiting PI3K-8/Akt pathway and increasing GR expression [ J ]. Am J Physiol Lung Cell Mol Physio1,2015 ,309 (2) : L139-L146.
5Rabe KF,Hurd S,Anxueto A,et al. Global strategy for the diagnosis, management, and prevention of chronie obstruetive pulmonary disease- 2006 update[ J ]. Am J Res Pir Crit Care Med,2007,176 (6): 532- 555.
6Li H, Yang T, Ning Q, et al. Cigarette smoke extract-treated mast cells promote alveolar macrophage infiltration and polarization in ex- perimental chronic obstructive pulmonary disease [ J ]. lnhal Toxicol, 2015,27 (14) :822-831.
7Singh D, Kolsum U, Brightling cE, et al. Eosinophilic inflammation in COPD : prevalence and clinical characteristics [ J ]. Eur Respir J, 2014,44 (6) : 1697-1700.
8Wan YF, Huang ZH, Jing K, et al. Azithromycin attenuates pulmo- nary inflammation and emphysema in smoking-induced COPD model in rats [ J ]. Respir Care,2015,60 ( 1 ) : 128-134.
9Jersild Jespersen M, Mygind LH, Vestbo J, et al. Sparse effect of long-term treatment with macrolides in patients with chronic obstruc- tive pulmonary disease[ J ]. Ugeskr Laeger,2013,175 (10) :648-651.
